Who's the daddy? US sperm banks must be better regulated
By Alison Motluk,
New Scientist
| 08. 09. 2007
CAREFUL,
exacting, high-tech - that's the image US sperm banks like to project
to their customers. They run limited genetic tests on their donors and
trace medical records back three generations. They also screen for
chemical exposure, drug use and even do complex psychological profiling.
Equally
interesting is what sperm banks don't do - and are not required to do
by law. They don't verify that all the medical or personal information
that donors give them is correct. They don't routinely test for the
majority of known genetic diseases. They do not confirm that the sperm
the woman requested is the sperm that ends up in her body. And they
don't always know where to find donors or recipient families should a
concern crop up.
Now
a small, not-for-profit company is beginning to fill in these gaps. In
doing so, it threatens to expose just how common errors in the American
fertility industry might be, and how little oversight exists to stop
these problems from happening or to deal with them if they do occur.
In January this year, the...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...